Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5085480 | 0.87 | PPARG (0.71) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL31253930 | 0.83 | ALDH1A1 (0.42) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL31253931 | 0.83 | ALDH1A1 (0.42) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL27746393 | 0.83 | LMNA (0.65) | TDP1KMT2ALMNAMAPK1ALDH1A1 | |
| SCHEMBL3674585 | 0.82 | PPARG (0.61) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL7349537 | 0.82 | RAB9A (0.44) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL4577944 | 0.81 | PPARG (0.65) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL28768397 | 0.81 | MAPT (0.53) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL1560611 | 0.81 | ALDH1A1 (0.43) | PPARGTDP1KMT2AMAPK1HIF1A | |
| SCHEMBL6243415 | 0.80 | PPARG (0.63) | PPARGTDP1KMT2ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035459-B1 | COVALENT CONJUGATES OF COTTON AND SUBSTITUTES (VISCOSE, MODAL COTTON) WITH BIOACTIVE SUBSTANCES HAVING ANTISEPTIC, SANITIZING, ACARICIDAL AND INSECT REPELLENT ACTIVITY, AND A METHOD FOR OBTAINING THEM | FRANZONI FILATI S P A (IT) | 2009-12-16 | — | — | EP | disclosed |
| EP-2035459-A2 | COVALENT CONJUGATES OF COTTON AND SUBSTITUTES (VISCOSE, MODAL COTTON) WITH BIOACTIVE SUBSTANCES HAVING ANTISEPTIC, SANITIZING, ACARICIDAL AND INSECT REPELLENT ACTIVITY, AND A METHOD FOR OBTAINING THEM | Franzoni Filati S.p.A. (IT) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007135548-A2 | COVALENT CONJUGATES OF COTTON AND SUBSTITUTES (VISCOSE, MODAL COTTON) WITH BIOACTIVE SUBSTANCES HAVING ANTISEPTIC, SANITIZING, ACARICIDAL AND INSECT REPELLENT ACTIVITY, AND A METHOD FOR OBTAINING THEM | FRANZONI FILATI S.P.A. (IT) | 2007-11-29 | — | — | WO | disclosed |
| US-20050059735-A1 | Cyclic amino acid derivatives useful as pharmaceutical agents | BRYANS JUSTIN STEPHEN (GB) | 2005-03-17 | — | — | US | disclosed |
| US-20030216469-A1 | Cyclic amino acid derivatives useful as pharmaceutical agents | BRYANS JUSTIN STEPHEN (GB) | 2003-11-20 | — | — | US | disclosed |
| EP-1284960-A1 | CYCLIC AMINO ACID DERIVATIVES USEFUL AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2003-02-26 | — | — | EP | disclosed |
| WO-2001090052-A1 | CYCLIC AMINO ACID DERIVATIVES USEFUL AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059735-A1 | Cyclic amino acid derivatives useful as pharmaceutical agents | QPCT, ARGLU1, PNISR | PPARG 3773/4885TDP1 2782/4885KMT2A 3098/4885 |
| US-20030216469-A1 | Cyclic amino acid derivatives useful as pharmaceutical agents | QPCT, ARGLU1, QPCTL | PPARG 4065/4885TDP1 2516/4885KMT2A 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.